Abstract
Cytochrome P450 3A4 and 3A7 (CYP3A4 and CYP3A7, respectively) are predominant forms in the human adult and fetal liver, respectively. 1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) is known to be a potent inducer of CYP3A4 in human colon carcinoma Caco-2 via vitamin D receptor (VDR). However, whether CYP3A7 is inducible by 1,25(OH)(2)D(3) has not yet been elucidated. In the present study, we examined the effect of 1,25(OH)(2)D(3) on CYP3A7 gene expression in Caco-2 cells, which express CYP3A4 and CYP3A7 mRNAs. 1,25(OH)(2)D(3) hardly induced the expression of CYP3A7 mRNA in contrast to the marked induction of CYP3A4 mRNA. Reporter assay using 5'-franking region CYP3A4 and CYP3A7 genes also revealed that 1,25(OH)(2)D(3) activates CYP3A4 promoter, but not CYP3A7 promoter, which has two mutations in the proximal ER6 site compared with CYP3A4 promoter. In addition, we found that the binding of VDR to the proximal ER6 in CYP3A7 gene was markedly less than that to the proximal ER6 in CYP3A4 gene using gel shift assay. Taken together, the decrease of VDR binding to the proximal ER6 caused by the mutation results in the loss of CYP3A7 gene activation by 1,25(OH)(2)D(3).
References
Apr 15, 1989·Gene·S N HoL R Pease
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J K BurmesterH F DeLuca
Aug 1, 1988·Biochemical Pharmacology·S A WrightonP S Guzelian
Oct 1, 1987·The Journal of Clinical Investigation·P B WatkinsP S Guzelian
Aug 14, 1996·Biochemical and Biophysical Research Communications·J GreuetP Maurel
Feb 1, 1996·Pharmacogenetics·D R NelsonD W Nebert
Mar 7, 1998·Cell·S A KliewerJ M Lehmann
Sep 3, 1998·The Journal of Clinical Investigation·J M LehmannS A Kliewer
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·G BertilssonA Berkenstam
Jul 15, 1999·Biochemical and Biophysical Research Communications·J M PascussiM J Vilarem
Dec 26, 2001·Molecular Pharmacology·Hirokazu Hara, Tetsuo Adachi
Apr 10, 2002·The Journal of Biological Chemistry·Oliver BurkLeszek Wojnowski
May 7, 2002·The Journal of Biological Chemistry·Lionel DrocourtMarie-José Vilarem
May 23, 2002·Science·Makoto MakishimaDavid J Mangelsdorf
Jul 20, 2002·Molecular Pharmacology·Bryan GoodwinChristopher Liddle
Jul 31, 2002·Biochemical and Biophysical Research Communications·Hirokazu HaraTetsuo Adachi
Jun 19, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoko YasunamiTetsuo Adachi
Citations
May 19, 2005·Pharmacogenetics and Genomics·Allan B OkeyPatricia A Harper
Mar 7, 2006·Pharmacogenomics·Guang-Ji WangHong-Guang Xie
Sep 4, 2012·Molecular and Cellular Endocrinology·Orla MaguirePaul Thompson
Mar 19, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·S HarmsenI Meijerman
Aug 26, 2019·Archives of Biochemistry and Biophysics·Haixing Li, Jed N Lampe